A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes
Clinical trial NCT06169982 · COMPLETED
Trial details
- NCT number
- NCT06169982
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-07
- Primary completion
- 2024-07-18
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.